Lung Cancer Clinical Trial
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
Summary
This is a Phase 1, open label, multi center, dose escalation and expansion, safety, tolerability, PK, and pharmacodynamics study of PF 06939999 in previously treated patients with advanced or metastatic cancer.
Eligibility Criteria
Inclusion Criteria:
Histologically or cytologically confirmed locally advanced or metastatic NSCLC, urothelial carcinoma or HNSCC
Progressed after at least 1 line of treatment and no more than 3 lines of treatment
At least one measurable lesion as defined by RECIST version 1.1
ECOG Performance Status 0 or 1
Adequate Bone Marrow Function
Adequate Renal Function
Adequate Liver Function
Resolved acute effects of any prior therapy
Exclusion Criteria:
Known active uncontrolled or symptomatic CNS metastases.
Major surgery, radiation therapy, systemic anti-cancer therapy or investigational drug(s) within 4 weeks prior to study entry.
Active, uncontrolled infection, including COVID-19
Known or suspected hypersensitivity to PF-06939999
Inability to consume or absorb study drug
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 14 Locations for this study
Scottsdale Arizona, 85258, United States
Scottsdale Arizona, 85258, United States
Los Angeles California, 90033, United States
Los Angeles California, 90033, United States
Los Angeles California, 90033, United States
Los Angeles California, 90033, United States
Pasadena California, 91105, United States
Celebration Florida, 34747, United States
Celebration Florida, 34747, United States
Miami Florida, 33136, United States
Orlando Florida, 32804, United States
Orlando Florida, 32804, United States
Orlando Florida, 32804, United States
Ann Arbor Michigan, 48106, United States
Brighton Michigan, 48114, United States
Nashville Tennessee, 37232, United States
Nashville Tennessee, 37232, United States
Houston Texas, 77030, United States
San Antonio Texas, 78229, United States
Fairfax Virginia, 22031, United States
Seattle Washington, 98109, United States
Seattle Washington, 98195, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.